Myron S. Czuczman
2023
In 2023, Myron S. Czuczman earned a total compensation of $1.2M as Chief Medical Officer and Executive Vice President at Citius Pharmaceuticals, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $133,875 |
|---|---|
| Option Awards | $599,127 |
| Salary | $437,500 |
| Total | $1,170,502 |
Czuczman received $599.1K in option awards, accounting for 51% of the total pay in 2023.
Czuczman also received $133.9K in non-equity incentive plan and $437.5K in salary.
Rankings
In 2023, Myron S. Czuczman's compensation ranked 931st out of 2,238 executives tracked by ExecPay. In other words, Czuczman earned more than 58.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 931 out of 2,238 | 58th |
Division Manufacturing | 547 out of 1,216 | 55th |
Major group Chemicals And Allied Products | 373 out of 683 | 45th |
Industry group Drugs | 363 out of 654 | 45th |
Industry Pharmaceutical Preparations | 248 out of 470 | 47th |
Source: SEC filing on January 26, 2024.
Czuczman's colleagues
We found two more compensation records of executives who worked with Myron S. Czuczman at Citius Pharmaceuticals in 2023.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020